NSAID and oesophageal adenocarcinoma: randomised trials needed to correct for bias

Lancet Oncol. 2006 Jan;7(1):7-8; author reply 8-9. doi: 10.1016/S1470-2045(05)70516-7.
No abstract available

Publication types

  • Comment
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma / etiology
  • Adenocarcinoma / prevention & control*
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
  • Barrett Esophagus / complications*
  • Barrett Esophagus / drug therapy
  • Esophageal Neoplasms / etiology
  • Esophageal Neoplasms / prevention & control*
  • Humans
  • Prognosis
  • Randomized Controlled Trials as Topic*
  • Reproducibility of Results
  • Research Design
  • Risk Factors
  • Survival

Substances

  • Anti-Inflammatory Agents, Non-Steroidal